News

Article October 7, 2019

New Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer’s Disease

Senior Investigator Katerina Akassoglou has fundamentally changed the way scientists think of neurological disorders. She made the seminal discovery that blood leaks are toxic to the brain by promoting inflammation and destroying neurons. Her research led the scientific community to reassess the complex relationship between the brain, immune, and vascular systems.

Business Development Institutional News Assay Development and Drug Discovery Core Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab

Article September 20, 2019

Gladstone’s Alzheimer Research Team: Ahead of the Curve

As clinical trials in Alzheimer's disease have failed, Gladstone investigators are taking innovative approaches to understanding the disease and finding new therapeutic targets.

Research (Publication) Alzheimer’s Disease Dementia Neurological Disease Huang Lab Mahley Lab Mucke Lab Palop Lab Aging Disease Models

Article March 19, 2019

New Study Resolves Debate about How the Brain’s Immune Cells Regenerate

Gladstone scientists investigate how microglial cells maintain their population

News Release Research (Publication) Alzheimer’s Disease Neurological Disease Gan Lab

Article February 14, 2019

One Copy of a Gene May Be Worse Than None at All

A team of researchers shows that missing one copy of the TREM2 gene can exacerbate Alzheimer’s disease pathology

News Release Research (Publication) Alzheimer’s Disease Neurological Disease Gan Lab Aging

Article February 5, 2019

A New Culprit of Cognitive Decline in Alzheimer’s Disease

Study finds blood protein destroys memory storage sites in the brain and may lead to new treatments

News Release Research (Publication) Alzheimer’s Disease Neurological Disease Akassoglou Lab Aging

Article November 5, 2018

New Insights into the Aging Brain

Gladstone scientists uncover new gatekeeper function of anti-aging molecule

News Release Research (Publication) Alzheimer’s Disease Neurological Disease Mucke Lab Aging

Article October 15, 2018

New Immunotherapy Targeting Blood-Clotting Protein Protects Multiple Sclerosis and Alzheimer’s Disease Models

Gladstone researchers have stopped the detrimental effects of blood-brain barrier leaks

News Release Research (Publication) Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab

Article August 27, 2018

Unearthing the Secrets of Cellular Energy

Scientists shed light on cells’ most fundamental process

News Release Research (Publication) Alzheimer’s Disease Neurological Disease Nakamura Lab CRISPR/Gene Editing

Article August 15, 2018

A New Research Partnership to Find Treatments for Neurological Disorders

BioMotiv and Cure Network Dolby Acceleration Partners collaborate to advance the development of better treatments for brain disorders

Corporate Liaison and Ventures Business Development News Release Alzheimer’s Disease Epilepsy Neurological Disease Palop Lab

Article July 3, 2018

Roddenberry Gift Ushers Gladstone Stem Cell Research into the Future

The path to medical breakthroughs lies in bold, ambitious science

Donor Stories Institutional News Spinal Cord Injuries Alzheimer’s Disease Diabetes Roddenberry Stem Cell Center Bruneau Lab Ding Lab Huang Lab McDevitt Lab

Article April 8, 2018

Deep Learning: A Superhuman Way to Look at Cells

Gladstone and Google AI collaborate to uncover the tip of an iceberg that could transform biomedical science
 

News Release Research (Publication) Alzheimer’s Disease Center for Systems and Therapeutics Neurological Disease Finkbeiner Lab AI

Article April 8, 2018

Scientists Fix Genetic Risk Factor for Alzheimer’s Disease in Human Brain Cells

New insights into how a gene causes damage could impact future drug development

News Release Research (Publication) Alzheimer’s Disease Neurological Disease Huang Lab

Article March 15, 2018

Cell Therapy Could Improve Brain Functions Impaired by Alzheimer’s Disease

Transplanting a special type of neuron into the brain restores cognitive functions in Alzheimer’s models

News Release Research (Publication) Alzheimer’s Disease Neurological Disease Mucke Lab Palop Lab

Article December 7, 2017

Gladstone Institutes Announces Research Collaboration with Lilly

Study will use innovative technology to focus on neurodegenerative diseases

Business Development News Release Alzheimer’s Disease Finkbeiner Lab

Article October 24, 2017

Tau: A Promising Target to Treat Alzheimer’s Disease

Gladstone scientists receive funding to develop new drugs to reduce tau levels in the brain

Assay Development and Drug Discovery Core Alzheimer’s Disease Mucke Lab